PNPLA3 and metabolic dysfunction-associated steatotic liver disease: So far, SNPs in patatin-like phospholipase domain-containing protein 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2) regions have been identified and validated in large cohorts of patients as a biomarker for NAFLD risk.